YOLO - AdvisorShares Pure Cannabis ETF

NYSEArca - Nasdaq Real Time Price. Currency in USD
18.20
-0.29 (-1.57%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close18.49
Open18.44
Bid17.96 x 1200
Ask18.25 x 1200
Day's Range18.10 - 18.48
52 Week Range16.93 - 26.50
Volume38,145
Avg. Volume45,584
Net Assets52.5M
NAV18.42
PE Ratio (TTM)N/A
YieldN/A
YTD ReturnN/A
Beta (3Y Monthly)N/A
Expense Ratio (net)0.74%
Inception Date2019-04-17
Trade prices are not sourced from all markets
  • Benzinga

    Podcast: The Evolution Of Cannabis Legalization With Benzinga's Javier Hasse

    Podcast via Kannaboomers . “ This is a social movement that is moving forward faster than any other social movement in the world and probably in history. “ — Javier Hasse History is being made, day by ...

  • Benzinga

    A Cannabis ETF Looking For Redemption

    Cannabis stocks and exchange traded funds endured a summer of woe. The actively managed AdvisorShares Pure Cannabis ETF (NYSE: YOLO ) is saddled with a third-quarter loss of 18.55%, but the fund's manager, ...

  • Benzinga

    Meet Pluto, The New Cannabis Brand That Just Gets What Cool People Like Nowadays

    Pluto is officially debuting this week at famed cannabis event Hall Of Flowers. “At Pluto, you will find a diversity of characters, from overlapping decades, peacefully coexisting with one another. Pluto is a cannabis concentrates maker.

  • Benzinga

    What Is The Future Of CBD Industry In The United States?

    The next day, it seems that CBD products and their advertisements are everywhere. Thanks to the Hemp Farming Act of 2018 signed by Donald Trump, CBD products are not only widely available in the US but is now very high demand. The farm bill made industrial hemp legal in addition to legalizing recreational and medical cannabis at the state level.

  • Benzinga

    How To Navigate The Cannabis ETF 'Craze'

    The launch of four new cannabis ETFs in 2019, paired with the recent filing for yet another one, has many investors wondering how to navigate amongst the options as they seek exposure to the growing cannabis industry. The oldest and still largest cannabis ETF on the market is the ETFMG Alternative Harvest ETF (NYSE: MJ). The MJ investment objective is quite broad, and an examination of the portfolio indicates more than 17% is allocated to tobacco stocks, with other sizable positions including fertilizer companies, breweries and real estate investment trusts (REITs).

  • Benzinga

    Cannabis Capital Raises Slow Down Alongside Capital Markets

    The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and intelligence they need to make informed decisions regarding deal valuations, terms, and structures. Since its inception, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,400 capital raises totaling over $29 billion as well as more than 800 M&A transactions.

  • Benzinga

    Florida's Vast Cannabis Market Potential Is The Difference Between 'And' Or 'Or'

    Florida has so much untapped marijuana and hemp potential. In Florida, medical marijuana is available for serious health conditions such as cancer, Crohn’s disease, multiple sclerosis and post-traumatic stress disorder, and chronic pain associated with those conditions. Since the state’s introduction of its medical marijuana laws in January of 2017, Florida has enrolled 350,000 patients according to the August 23, 2019 report from the Office of Medical Marijuana Use.

  • Benzinga

    Feds To Propose Boost In Marijuana Quota For Research, Cut To Opioid Manufacturing Limit

    Federal drug enforcement officials want to boost the amount of marijuana that can be legally produced for research in the United States while cutting the number of opioids that can be manufactured in the country. The U.S. Drug Enforcement Administration said in a press release Wednesday that it will propose to boost the amount of marijuana produced for research next year by nearly a third, to 3,200 kilograms. The agency said that over the last two years the number of people registered by the DEA to conduct research with marijuana, marijuana extracts and derivatives has increased by more than 40%, making the increase in production necessary.

  • Benzinga

    Cannabis Has Already Contributed More Than $100M To The State Of Nevada This Year

    Cannabis dispensaries, cultivators, laboratories and producers have paid more than $109 million in excise taxes and fees over the course of fiscal year 2019, breaking the $100 million mark for the first time. While the state has not yet disclosed how much of that went to education this year, changes to the law under the leadership of Gov. Steve Sisolak mandate that 100% of taxes go to education in future years. For the next two years, the state is projecting more than $100 million per year in tax collections.

  • Benzinga

    Cannabis M&A And Financings Nearing $10 Billion YTD, Up 77% YoY

    The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and intelligence they need to make informed decisions regarding deal valuations, terms, and structures. Since its inception, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,400 capital raises totaling over $29 billion as well as more than 800 M&A transactions.

  • Benzinga

    Out Of Luck: NFL Champs Are Leaving The Game In Droves – And Getting Into Cannabis

    Will early retirements get the NFL to change its tune on cannabis? On a Saturday evening, about two weeks before the beginning of the 2019 NFL season, 29-year-old Indianapolis Colts quarterback Andrew Luck stood in front of the press as he often did. Instead, Luck stunned the league, shocked his fans, and torpedoed fantasy football rosters across the country by announcing his early retirement from football.

  • Benzinga

    New York Fashion Week Goes Green With Korto Momolu's Cannabis Collaboration

    On Sept. 7, a weed-themed show is hitting the runway, product of a collaboration between bold fashion designer Korto Momolu — featured on the show "Project Runway" — and Women Grow, the largest networking organization for women in the cannabis and hemp industries.

  • Barrons.com

    Why the Future of Marijuana Stocks Is American, Not Canadian, According to an Analyst

    Marijuana stocks in the U.S. will struggle as long as the drug remains illegal on a federal basis. But one analyst sees the tide turning, and these stocks popping.

  • This business ethicist weighs in on which kind of cannabis stocks are morally OK
    MarketWatch

    This business ethicist weighs in on which kind of cannabis stocks are morally OK

    Does owning marijuana stocks raise the same ethical issues as owning stocks in an alcohol or tobacco firm?

  • Benzinga

    High Tunes: How Cannabis Dispensaries Choose Their Soundtracks And How They Impact Sales

    For many dispensaries, the music playlists offer a window into an operation’s overall philosophy and ethos. What’s the first thing you notice when you step inside a dispensary? Once upon a time, it was likely the aroma of cannabis beckoning you in like Pepé Le Pew.

  • Benzinga

    FDA To Re-Open Public Comments On Descheduling Cannabis Under International Treaty

    The U.S. Food and Drug Administration issued a notice Wednesday that it will give people more chances to comment on the question of dropping cannabis from the most restricted class of drugs for the purposes of international treaties. An unpublished notice was filed Wednesday by the FDA in the Federal Register indicating it will officially open comments on the issue on Thursday. Cannabis currently is in the category of the most controlled substances under a 1961 international treaty, deemed to be more dangerous than any therapeutic benefits are worth.

  • Benzinga

    How Does Weed Impact Sex? New Report Offers Answers

    To better understand the plant’s impact on sex, Eaze partnered with Lioness — maker of smart vibrators with climax-tracking sensors — to study THC and CBD in the bedroom. While a satisfying sex life is the result of many variables, cannabis can increase the length, frequency, and quality of your orgasms and pleasure sessions whether you’re single or married, solo or with a partner, young adult or silver fox. The survey was conducted by MarketView Research and completed by 432 Lioness newsletter subscribers across North America from 6/23 to 7/1, and consisted of all genders and non-gender-conforming consumers.

  • Benzinga

    Investment Opportunities Grow As Cannabis Expands Into New Consumer Markets

    For years, friends and family and angel investors were the primary funding sources for cannabis ventures, as only those closest to the industry were willing to take the risks that came with investing in a sector that, while increasingly legal at the state level, was (and is) still illegal federally in the United States. While those early investors continue to be important, we’re starting to see more institutional investors make moves into cannabis. While cannabis might be unusual in its legal status, the investment path it is following is well trod.

  • Benzinga

    Researchers Unlock What Gives Cannabis Its Anti-Inflammatory Qualities

    A new study deciphers for the first time the cannabis plant's biological blueprint for producing two molecules thought to have anti-inflammatory properties, a discovery that could pave the way for expanded use of cannabis as medicine.

  • Benzinga

    Muisca Capital Group's Carol Ortega On Why Cannabis Could Outgrow Colombia's Coffee, Flower And Banana Industries

    With more than 600 million inhabitants, the region's legal cannabis market is expected to reach $13 billion by 2028. Benzinga spoke with Carol Ortega, the managing director and founder of Muisca Capital Group, a Latin America-focused venture capital firm serving the legal cannabis industry in the U.S. and Colombia. Muisca Capital Group is the first Latino-focused venture capital firm providing professional services to the legal cannabis industry in the U.S. and Colombia, Ortega said.

  • Benzinga

    Meet GEN!US, The New, Beautiful Cannabis Brand Focused On Creativity

    “GEN!US is curated intentionally to aid the thinking process, open neural pathways and break down mental barriers for today’s modern cannabis connoisseur,” according to a press release. A GEN!US spokesperson says the brand was created for creative people, crafted by a group of microbiologists, chemists, engineers and cannabis veterans who partnered up with their favorite cannabis growers. “GEN!US is not a title, but an untapped destination within us that is waiting to be unleashed,” 25-year-old CEO Chris Clifford said.

  • Why Investors Should Trade Cautiously With Hexo Stock
    InvestorPlace

    Why Investors Should Trade Cautiously With Hexo Stock

    Ever since it reported quarterly results on June 13, HEXO (NYSE:HEXO) stock continued its downtrend. At a recent price of $4.23, the stock is getting close to falling below the symbolic $1 billion CAD ($750 million) market capitalization. Growing bearishness around cannabis stocks and the uncertainties around the company's growth prospects are hurting HEXO stock. Then, last month, its key brand executive stepped down from the position. What will it take to get investors interested in the company again?Source: Shutterstock On July 18, Hexo's co-founder and chief brand officer, Adam Miron, stepped down from his position. He will retain his seat on the Hexo Board of directors. Miron may have decided to leave the company because of regulator Health Canada slowing the pace of growth in the industry. Excessive regulations and slow decision-making took away the growth momentum for Hexo and the cannabis market in the last year. Sebastien St-Louis, Hexo's co-founder, said just about what you'd expect: "I respect his decision to take on new challenges and focus on his true passion: building."The Hexo stock price is down more than 40% in the past three months, versus the near-25% decline in the cash-heavy exchange-traded fund AdvisorShares Pure Cannabis ETF (NYSEArca:YOLO). Hexo is the fifth-largest equities holding in the marijuana fund's 28 constituents, at 4.72% of the portfolio. YOLO has a ~17% cash position.InvestorPlace - Stock Market News, Stock Advice & Trading Tips New C's in the C-suiteIn its Q3 2019, Hexo added a new COO, Donald Courtney, who has notable experience at Pepsi Bottling Group, Mars, and as head of MedReleaf. Michael Monahan joined the company as its new CFO. His chief responsibility is driving Hexo's global strategy. By expanding outside of the U.S., the company will have less geographic risks and a bigger addressable market. As more countries legalize cannabis, Hexo's addressable market will expand. These additional executive members will lead the 25 PhDs that the company has on staff. * 10 Stocks Under $5 to Buy for Fall Last quarter, Hexo secured around 200,000 kilograms of hemp supply for CBD and non-THC cannabinoid extraction for fiscal 2020. It has a secondary supply agreement of around 60,000 kilograms of hemp that will be supplied in the next two quarters. Hexo is gearing up for upcoming demand in edibles and concentrates, pending legalization in October in Canada. It signed a multi-year extraction agreement with Valens. This will add 30,000 kilograms of output in the first year and 50,000 kilograms of cannabis and hemp biomass in the second year. Collectively, Hexo has a near-term target of having 150,000 kilograms of supply. Greenhouse Helps Double OutputTo date, Hexo sold over 7.5 million grams of adult-use medical cannabis to Canadians. In the last quarter, sales increased 9% to 2,700 adult-use grams and grams equivalent. As its distribution across the Great White North expands, expect sales from this segment growing.Hexo produced ~9.8 tons of dried gram equivalent (9,800 kilograms). Output increased 98% sequentially after yields increased from its 250,000-square-foot B6 greenhouse. It also benefited from the first harvest at its 1-million-square-foot B9 greenhouse.Looking ahead, the company is prepared for the legalization of edibles and concentrates in October 2019. But the big risk here is any Canadian regulatory delays. This would push Hexo's phase two adult-use output into December. To mitigate these risks, the company is developing CBD gummies, a premium vape line, and cannabis-infused beverages in partnership with Truss, its joint venture with Molson Coors Canada that was announced in October 2018. Pricing HeadwindA drop in gross margins is a major risk for Hexo shareholders. Though the company reported a gross margin of 49% on net revenue, it expects price pressures ahead, as CEO St. Louis said on the recent conference call. "We do expect over the next 24 months as there is significant pricing compression that the flower might gradually gross margins towards the 40% level," he told participants. * 10 Undervalued Stocks With Breakout Potential Despite the pricing compression, Hexo expects its introduction of more advanced products will push the gross margin back toward 50%. Hexo Stock Valuation and Your TakeawayHexo will report quarterly results on Sept. 12 after the market closes. Two analysts who cover Hexo stock have a 125% upside target price (per TipRanks). Realistically, number-crunching a fair value on Hexo at this time is difficult (per finbox.io).Forecasting its revenue is difficult without knowing when the Canadian government will finalize the regulations. Hexo forecast FY2020 revenue of over $400 million CAD, which is multiples bigger than its $15.9 million CAD ($63.9 million CAD annualized) reported in the third quarter.Investors are taking a wait and see approach. As stocks like Tilray (NASDAQ:TLRY) or CannTrust (NASDAQ:CTST) fall, investors want more proof that revenue growth is sustainable and profits are achievable. HEXO stock investors need the market warming up to cannabis stocks again. It must also meet its revenue projections to win back investors.Disclosure: As of this writing, the author did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Marijuana Stocks to Ride High on the Farm Bill * 8 Biotech Stocks to Watch After the Q2 Earnings Season * 7 Unusual, Growth-Oriented REITs to Buy for Your Portfolio The post Why Investors Should Trade Cautiously With Hexo Stock appeared first on InvestorPlace.

  • Benzinga

    Is Weed The New Beer? 3 Key Stats Give Us An Idea

    Headset has released a new industry report with insights about cannabis-infused beverages. The firm took a deep dive into the stats of the beverage market including data from Colorado, Washington and Nevada, hitting points about infused beverages, a breakdown of what is selling by state, data on who is drinking what and more. Headset concluded the cannabis-infused beverage category meets a need that people didn’t even know they had.

  • Benzinga

    Another Cannabis ETF Is In The Works

    After three new marijuana exchange traded funds launched in July, bringing the total of cannabis ETFs listed in New York to five, another competitor could be coming to market. What Happened AdvisorShares, ...

  • Benzinga

    Defying The Odds With A Dream, Some Weed, And A Ton Of Determination: The Inside Scoop On Frank Shamrock

    Ortiz had three consecutive wins before the fight, with one being a 0:16 submission against Jeremy Screeton.  He was also noticeably bigger than Shamrock, and had more fights under his belt. Despite landing some pretty heavy blows in the first three rounds, Ortiz did begin to tire by the fourth round, and that’s when Shamrock dropped a calamitous elbow that landed with what I can only imagine being similar to the force of a Nimitz class aircraft carrier. You see, these guys aren’t street thugs.  They’re not hot-headed bar fighters looking to blow off some steam.  These guys are some of the most gifted  and well-disciplined athletes on the planet.  The sacrifice and dedication it takes to get to this level is almost inhuman.  But it’s also the kind of sacrifice and dedication that can make these guys successful in anything they choose to do.  And there is no better example of this than Frank Shamrock.